Tamoxifen in platinum-refractory ovarian cancer: a Gynecologic Oncology Group Ancillary Report.

MLA

Markman, M., et al. “Tamoxifen in Platinum-Refractory Ovarian Cancer: A Gynecologic Oncology Group Ancillary Report.” Gynecologic Oncology, vol. 62, no. 1, July 1996, pp. 4–6. EBSCOhost, https://doi.org/10.1006/gyno.1996.0181.

APA

Markman, M., Iseminger, K. A., Hatch, K. D., Creasman, W. T., Barnes, W., & Dubeshter, B. (1996). Tamoxifen in platinum-refractory ovarian cancer: a Gynecologic Oncology Group Ancillary Report. Gynecologic Oncology, 62(1), 4–6. https://doi.org/10.1006/gyno.1996.0181

Chicago

Markman, M, K A Iseminger, K D Hatch, W T Creasman, W Barnes, and B Dubeshter. 1996. “Tamoxifen in Platinum-Refractory Ovarian Cancer: A Gynecologic Oncology Group Ancillary Report.” Gynecologic Oncology 62 (1): 4–6. doi:10.1006/gyno.1996.0181.